AstraZeneca AB et al v. Torrent Pharmaceuticals Ltd. et al > Summary
Court Case Number 1:21-cv-01116
Filing Date Jul 30, 2021
Termination Date Nov 23, 2022
Court Delaware District Court
Status Judgment - Judgment on Consent
JudgesRichard G. Andrews
Plaintiff
Plaintiff Attorneys
5AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Mark J. Feldstein
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Ryan P. O'Quinn
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
Defendant Attorneys
5Torrent Pharmaceuticals
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
Torrent Pharmaceuticals
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
Torrent Pharma Inc.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
Torrent Pharma Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
Torrent Pharmaceuticals
Attorney Name: April M. Kirby
Abrams & Bayliss LLP
Counter Defendant
3AstraZeneca
Attorney Name: Alexandra M. Joyce
McCarter & English
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
Counter Claimant
4Torrent Pharmaceuticals
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
Torrent Pharmaceuticals
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
Torrent Pharma Inc.
Attorney Name: April M. Ferraro
Abrams & Bayliss LLP
Torrent Pharma Inc.
Attorney Name: John M. Seaman
Abrams & Bayliss LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10300065 | Method of treating or prevention of atherothrombotic events in patients with history of myocardial infarction | May 28, 2019 |
